Valuation: Nephros, Inc.

Market Cap 38.11M 33.11M 30.87M 28.38M 53.52M 3.63B 54.46M 364M 143M 1.81B 143M 140M 6B P/E 2026 *
87.8x
P/E 2027 * 24.2x
Enterprise Value 38.11M 33.11M 30.87M 28.38M 53.52M 3.63B 54.46M 364M 143M 1.81B 143M 140M 6B EV / Sales 2026 *
1.82x
EV / Sales 2027 * 1.6x
Free-Float
87.13%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Nephros, Inc.

Manager TitleAgeSince
Chief Executive Officer 51 2023-05-04
Director of Finance/CFO 60 2023-10-31
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 69 2007-09-18
Director/Board Member 54 2018-08-09
Director/Board Member 58 2022-09-07
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-1.69% - - 36.8M
+0.41%-15.98% - - 14.58B
+1.89%+3.48%+35.49%+52.17% 10.92B
-0.24%-3.27%+56.46%+262.50% 4.24B
+3.70%-9.65%+51.41%+480.05% 3.85B
-5.12%-12.63%+35.48%+70.09% 1.24B
-2.83%-16.29% - - 1.08B
+1.05%+4.86%-20.78%-14.07% 910M
+0.63%-0.35%+121.63%+124.15% 876M
+0.27%-1.40%+186.37%+177.71% 750M
Average -0.02%-4.73%+66.58%+164.66% 4.27B
Weighted average by Cap. +0.84%-7.76%+48.11%+168.77%

Financials

2026 *2027 *
Net sales 20.92M 18.18M 16.95M 15.58M 29.38M 1.99B 29.9M 200M 78.3M 994M 78.56M 76.83M 3.29B 23.8M 20.68M 19.29M 17.73M 33.43M 2.27B 34.02M 228M 89.1M 1.13B 89.39M 87.42M 3.75B
Net income 461K 401K 374K 344K 648K 43.98M 659K 4.41M 1.73M 21.92M 1.73M 1.69M 72.66M 1.63M 1.42M 1.32M 1.21M 2.29M 155M 2.33M 15.6M 6.11M 77.5M 6.12M 5.99M 257M
Net Debt - -
Logo Nephros, Inc.
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-